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Abstract
Background: The rodent borne Puumala hantavirus (PUUV) causes haemorrhagic fever with renal syndrome in
central and northern Europe. The number of cases has increased and northern Sweden has experienced large
outbreaks in 1998 and 2006–2007 which raised questions regarding the level of immunity in the human
population.
Methods: A randomly selected population aged between 25 and 74 years from northern Sweden were invited
during 2009 to participate in a WHO project for monitoring of trends and determinants in cardiovascular disease.
Health and risk factors were evaluated and sera from 1,600 participants were available for analysis for specific PUUV
IgG antibodies using a recombinant PUUV nucleocapsid protein ELISA.
Results: The overall seroprevalence in the investigated population was 13.4 %, which is a 50 % increase compared to a
similar study only two decades previously. The prevalence of PUUV IgG increased with age, and among 65–75 years it
was 22 %. More men (15.3 %) than women (11.4 %) were seropositive (p < 0.05). The identified risk factors were
smoking (OR = 1.67), living in rural areas (OR = 1.92), and owning farmland or forest (OR = 2.44). No associations were
found between previous PUUV exposure and chronic lung disease, diabetes, hypertension, renal dysfunction, stroke or
myocardial infarction.
Conclusions: PUUV is a common infection in northern Sweden and there is a high life time risk to acquire PUUV
infection in endemic areas. Certain risk factors as living in rural areas and smoking were identified. Groups with
increased risk should be targeted for future vaccination when available, and should also be informed about appropriate
protection from rodent secreta.
Keywords: Emerging infection, Hantavirus, Haemhorrhagic fever with renal syndrome, Puumala, seroepidemiology,
Risk factors,
Background
Hantaviruses of the Bunyaviridae family are globally
spread and each human pathogenic hantavirus is carried
by different rodents [1]. The virus is mostly transmitted
to humans by inhalation of virus particles present in
rodent secreta and cause haemorrhagic fever with renal
syndrome (HFRS) or hantavirus pulmonary syndrome
(HPS) depending on the hantavirus species. HFRS in
Asia is caused by Hantaan and Seoul viruses, and in
central and northern Europe Puumala virus (PUUV) is
the endemic hantavirus whereas Dobrava virus is found
in the Balkans [1]. In the Americas, Andes, Sin Nombre
and related viruses cause HPS which is a more severe in-
fection. The prodrome in HPS is similar to HFRS,
however the disease often proceeds into cardiopulmo-
nary failure, with a case-fatality rate up to 40 % [1]. In
Scandinavia, the only human pathogenic hantavirus rec-
ognized so far is PUUV which causes a less severe HFRS,
also denoted nephropathia epidemica characterized by
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abrupt onset of fever, resembling influenza with myalgia,
headache, fatigue and varying degrees of renal impairment
[2]. In addition, abdominal pain, nausea, vomiting, and
backache may be present [3]. The seroprevalence has pre-
viously been estimated at 9 % in northern Sweden [4]. In
Sweden, PUUV infection is a notifiable disease and the re-
ported incidence rate varies from 20 to 313 per 100,000
persons each year, but the real figure is considered to be
seven to eight times higher [5, 6]. Hantavirus antibodies
have been found more than 50 years after a diagnosed
PUUV infection, and life-long immunity is suggested [7].
The primary reservoir is bank voles, Myodes glareolus,
and the incidence of PUUV infection is correlated to the
size of the bank vole populations [1]. Person-to-person
transmission has been shown for the South American
Andes hantavirus [8]. In Europe, transmission between
humans has not been reported, although PUUV has been
detected in human saliva [9]. Known risk factors for con-
tracting the infection are agricultural work and activities
in peridomestic areas such as cleaning of sheds or summer
cottages, wood handling and smoking [2, 10–13]. The
case-fatality rate is less than 1 % [7, 11] and PUUV infec-
tion has generally a favourable prognosis. However, car-
diopulmonary involvement, increased risk for myocardial
infarction, stroke, and hormonal deficiencies may occur
during and after the infection [14–16].
Furthermore, several studies indicate possible associ-
ation to hypertension and renal impairment [17, 18]
although the findings have been contradictory [19].
During the winter 2006–2007 a very large outbreak of
PUUV infection occurred in northern Sweden [6]. This
sudden outbreak raised questions regarding the level of
immunity against PUUV among the population, risk
factors for disease and health consequences.
The aims of the present study were; to define the
current seroprevalence of PUUV infection in northern
Sweden; to define risk factors for infection, and link
these findings to demographic and health data in a large,
randomly selected and stratified population sample. In
addition, we investigated potential associations between
previous PUUV infection and cardiovascular risk factors
and/or chronic diseases.
Methods
Study site and population
The MONICA project, “Multinational Monitoring of
Trends and Determinants in Cardiovascular Disease” was
initiated by the World Health Organisation (WHO) in
1982. The purpose was to study levels, trends and risk
factors of stroke and coronary disease globally [20]. In
northern Sweden, the counties of Norrbotten and
Västerbotten, with a combined population of approximately
500,000 inhabitants, joined the MONICA project in 1985
[21]. When the official WHO assignment was concluded in
1994, the project continued as the Northern Sweden
MONICA study.
During spring 2009, 2,500 individuals from the
counties of Norrbotten and Västerbotten were randomly
selected. 250 males and 250 females from each age
group 25–34, 25–44, 45–54, 55–64 and 65–74 were
invited to participate. After signing a written consent,
they received a free health check including measuring of
arterial blood pressure, waist − hip ratio and Body Mass
Index (BMI). Levels of S −Creatinine were measured.
A questionnaire regarding quality of life, previous and
present illness, social support, health, work, physical
activity, diet and use of tobacco was answered.
Subjects not responding to the study invitation (n = 771),
were contacted and asked to complete a basic questionnaire
of which 485 answered. They were on average younger
(46.7 vs. 50.8 years, p < 0.001), less likely to being married/
cohabitant (63.6 % vs. 73.9 %, p < 0.001), and less likely to
have a university education (23.9 % vs. 29.9 %, p = 0.010)
than the participants. They more often reported themselves
as diabetics (7.7 % vs. 4.8 %, p = 0.013), and as smokers
(17.5 % vs. 11.0 %, p < 0.001). BMI, based on self − reported
height and weight, was equivalent to the BMI measured in
participants (data not shown). Treatment with hypertensive
medication (22.7 % vs. 19.3 %, p = 0.106) and lipid − lower-
ing drugs (9.1 % vs. 12.4 %, p = 0.052) did not differ signifi-
cantly between participants and non − participants.
Definitions
Rural areas were defined as communities having less
than 1,000 inhabitants. The municipalities of the
counties of Västerbotten and Norrbotten were divided
into inland or coastal. The participants stated their
highest educational level as primary school (up to nine
years of school), secondary school (ten to twelve years of
school) or university studies (higher education). The
participants were asked to describe their main occupa-
tion, descriptions later classified according to the
“Nordic standard of occupational classification” of 1985
[22]. In order to identify possible occupational risks for
hantavirus infection, occupations with similar assumed
exposure were grouped together as; 1) office personnel;
2) teaching, clergy, police and military; 3) healthcare
workers; 4) construction, wood industry and plumbers;
5) engineers; 6) transportation, trade and service; 7)
industry; 8) agricultural work. In addition, it was asked
whether the participants were owners of farmland or
forests.
Smoking habits were classified as regular smoker,
smoking a least one cigarette a day, or non-smokers
[23]. Individuals were asked to rank their own present
health in one of five categories; 1) Very well, 2) Quite
well, 3) In between, 4) Quite bad, 5) Bad. In the analysis
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we merged categories one and two as “satisfying health”
and categories three until five as “unsatisfying health”.
Blood pressure was measured in a standardized manner,
mean value of two measurements, taken with Hawksley’s
random − zero sphygmomanometer. Hypertension was
defined as a mean systolic blood pressure ≥ 140 mmHg or a
mean diastolic blood pressure ≥ 90 mmHg or use of hyper-
tensive medication. Questions about asthma, chronic
obstructive pulmonary disease, diabetes, stroke and hospi-
talisation for acute myocardial infarction were answered
with yes or no. Renal affection was measured according to
the CKD − EPI (Chronic Kidney Disease Epidemiology
Collaboration) equation, glomerular filtration rate (GFR) =
141 ×min(Scr/κ,1)α ×max(Scr/κ, 1)–1.209 × 0.993Age × 1.018
(if female) × 1.159 (if black) (Scr is serum creatinine (mg/
dL), κ is 0.7 for females and 0.9 for males, α is −0.329 for fe-
males and −0.411 for males, min indicates the minimum of
Scr/κ or 1, and max indicates the maximum of Scr/κ or 1.
Laboratory methods/analysis
To perform the indirect enzyme − linked immunosorb-
ent assay (ELISA), 96 −well microtiter plates (NUNC
Immuno plates) were coated with PUUV nucleocapsid
protein (diluted 1/600 in PBS) produced in Escherichia
coli as previously described [24]. The plates were stored
at −80 °C until usage when they were thawed, washed
once with PBS − 0.05 % Tween (PBS − T), blocked with
blocking/dilution buffer (1 % non − fat dry milk in PBS
− 0.05 % Tween 20) and then washed again with PBS −
T. Samples and controls were diluted to 1/420 in dilu-
tion buffer and 190 μl was added to the blocked plate.
The plates were then either incubated at 4 °C overnight
or at 37 °C for 2 h. After incubation, the plates were
washed four times with PBS −T and the secondary anti-
body (goat α − human IgG conjugated with alkaline
phosphatase (Invitrogen AHI0305) diluted to 1/6,000 in
dilution buffer was added and incubated for 1 h at 37 °C.
One tablet of 4 −Nitrophenyl phosphate disodium salt
hexahydrate, pNPP (Sigma S0942 − 200TAB) was dis-
solved in 5 ml diethanol amine buffer and 100 μl was
added to the plates after 4 washes with PBS −T. The
plates were incubated at 37 °C for 30 min and the reaction
was stopped with 50 μl 3 M NaOH. The absorbance at
405 nm (OD) was measured.
For cut − off calculations, 106 sera from children under
the age of 5 years old were analysed as above. From these
results the cut off was calculated as mean + 3 standard de-
viations (SD), corresponding to an OD value of 0.240.
Statistical analysis
Binary logistic regression was used for simple group
comparisons. To simultaneously analyse several possible
risk factors associated with hantavirus infection (including
sex, age, education, smoking, occupation, urban or rural
environment, and coastal or inland living area), multiple
logistic regression was used. Outcome was presented by
odds ratios (OR) with corresponding 95 % confidence in-
tervals (CI). The level of statistical significance was set to
0.05. Statistical analyses were carried out using SPSS 18.1.
Non-responders and responders were compared using
t-test for continuous variables and X2-test for categorical
variables.
Results
Of the 2,500 men and women who were invited to the
survey, 1,729 (69.2 %) participated. Of these, blood
samples were available for testing in 1600 individuals.
The overall prevalence of PUUV IgG antibodies in
serum was 13.4 % (n = 214), and significantly higher in
men than in women (15.3 % vs 11.4 %, p < 0.05). There
was an increasing seropositivity associated to older age
for both sexes. In the age group 65–75 years, the
prevalence was 22 % (Table 1). Significantly higher
seroprevalence was found in rural compared to urban
areas (22.8 % vs. 10.9 %), and a living in inland
compared to coastal municipalities was associated with
higher prevalence (16.1 % vs. 12.2 %) (Table 1).
There was a significantly higher seroprevalence in
smokers than in non − smokers (20.6 % vs. 12.3 %)
(Table 2). There were a small but not significant differ-
ence in seroprevalence in participants with higher
compared to lower education level (9.5 % vs. 15 %)
(Table 2). Regarding occupational risks, agricultural
workers showed a prevalence of 31 %, compared to
office personnel 9 % (p < 0.001). However, this difference
was not significant in the multiple regression analyses
when adjusted for sex, age, education, smoking, and
living area (Table 2).
The highest prevalence of PUUV antibodies was found
in farm- or forest owners; 36 %, and the risk was signifi-
cantly increased; OR 2.44 (95 % 1.30–4.59) when
compared with non-farm- or forest owners.
No relation was found between the presence of PUUV
antibodies and hypertension, renal impairment, or self--
reported asthma, chronic obstructive pulmonary disease,
diabetes, previous acute myocardial infarction or cere-
bral insult (Additional file 1: Table S1). Also, there was
no correlation between positive hantavirus serology and
present unsatisfying self − assessed global health (Add-
itional file 1: Table S1).
Discussion
The prevalence of PUUV antibodies found in this
population based cohort was 13.4 % which is higher than
previously reported from the same area. A similar study in
Northern Sweden in 1990, established a seroprevalence of
8.9 % [4]. The increased seroprevalence is consistent with
a reported increased incidence of PUUV infection both in
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Sweden and Finland and several outbreaks since 1990 as
well as the large outbreak 2007 in Sweden [6, 7]. This indi-
cates that PUUV infection is increasing in Fennoscandia
and should be recognized as an important viral infection
in endemic areas. Our data revealed that every fourth man
and every fifth woman in Northern Sweden had experi-
enced infection with PUUV at age 65–74 years. This find-
ing indeed confirmed a high life time risk for both men
and women to acquire PUUV infection in endemic areas.
The high seroprevalence confirmed the notion that the
infection is under-diagnosed and most cases are not
reported. This could partly be explained by the various
different, unspecific symptoms of PUUV infection that
could make diagnosis difficult [3]. Also, many partici-
pants may not have attended health care facilities since
symptoms could be mild and be similar to influenza.
Notably, smokers in our study had an increased risk of
previous PUUV infection with an odds ratio of 1.7 (CI
1.1 − 2.5), even after adjusting for age, sex, level of
education, and living area. This finding is in accordance
with previous case-control studies from Finland and
Sweden [12, 13]. It is believed that smokers have an
Table 2 Seroprevalence towards PUUV in relation to smoking, education, farming and other occupations





n (% of study population) n (%) Odds ratio
(OR)
95 % CIa of
OR
Smoking (n = 1586) No 1411 (89.0 %) 174 (12.3 %) 1 -
Yes 175 (11.0 %) 36 (20.6 %) 1.67 1.11 − 2.52
Level of education (n = 1555) Primary and secondary school 1128 (70.5 %) 169 (15 %) 1 -
University education 427 (39.5 %) 45 (9.5 %) 0.80 0.58 − 1.09
Owner of farm/forest (n =
1600)
No 1545 (96.6 %) 194 (12.6 %) 1 -
Yes 55 (3.4 %) 20 (36.4 %) 2.44 1.30–4.59
Occupation (n = 1410) Office personnel 268 (19.0 %) 26 (9.7 %) 1 -
Teaching, clergy, police, military 207 (14.7 %) 23 (11.1 %) 1.25 0.66–2.37
Healthcare workers 238 (16.9 %) 30 (13.7 %) 1.53 0.86–2.72
Construction, wood industry,
plumbery
73 (5.2 %) 10 (13.7 %) 1.42 0.61–3.30
Engineers 166 (11.8 %) 25 (15.1 %) 1.68 0.89–3.18
Transportation, trade and service 279 (19.8 %) 36 (12.9 %) 1.23 0.70–2.16
Industry 143 (10.1 %) 26 (18.2 %) 1.79 0.94–3.39
Agricultural work 36 (2.6 %) 11 (30.6 %) 2.47 0.99–6.15
aConfidence interval. Significant results are shown in bold formatting
Table 1 Previous PUUV infection in relation to sex, age group, environment, and region
Variable (Valid observations) Subjects within each group Seropositity for PUUV Multiple logistic regression
n (% of study population) n (%) Odds ratio (OR) 95 % CIa of OR
Total study population 1600 (100 %) 214 (13.4 %) - -
Sex Women 789 (49.3 %) 90 (11.4 %) 1 -
Men 811 (50.7 %) 124 (15.3 %) 1.40 1.05 − 1.88
Age 25 − 34 years 246 (15.4 %) 12 (4.9 %) 1 -
35 − 44 years 326 (20.4 %) 22 (6.7 %) 1.41 0.68 − 2.91
45 − 54 years 313 (19.6 %) 43 (13.7 %) 3.11 1.60 − 6.03
55 − 64 years 354 (22.1 %) 57 (16.1 %) 3.74 1.96 − 7.14
65 − 74 years 361 (22.6 %) 80 (22.2 %) 5.55 2.95 − 10.44
Environmentb (n = 1560) Urban 1253 (80.3 %) 137 (10.9 %) 1 -
Rural 307 (19.7 %) 70 (22.8 %) 1.92 1.38 − 2.67
Region (n = 1600) Coast 1115 (69.7 %) 136 (12.2 %) 1 -
Inland 485 (30.3 %) 78 (16.1 %) 1.29 0.95 − 1.75
aConfidence interval. b40 subjects could not be classified according to this variable. Significant results are shown in bold formatting
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increased risk to catch and to become more severely ill
from respiratory, viral, and bacterial infections [25]. If
the increased risk for smokers to get PUUV infection is
connected to immunological mechanisms, the state of
the respiratory tract, particles in cigarette smoke, or is
behaviourally related remains unclear.
Furthermore, in accordance with previous findings,
there was a strong relation between living in rural,
forested areas or close to farms and being at risk of
hantavirus infection [12, 13]. Risk factors like living in
near contact with rodents, wood handling, farming,
forestry work and cleaning sheds and shelters are more
likely in rural areas [13]. Our results support previous
studies where an increased risk of hantavirus infection
to those engaged in farming and forestry [5, 10].
There was a non-significant higher seroprevalence of
those in agricultural work and industrial occupations
potentially due to more rodent contact. PUUV infection
is more often diagnosed in males and is suggested to
reflect increased exposure in male’s recreational and oc-
cupational activities [7]. Men are more often farm- and
forest-owners, among which recognition of symptoms as
well as notification is well established [7, 3]. In the
present study there was a significantly higher seropreva-
lence in men compared to women. A previous study
showed similar trend but no statistical significant differ-
ence in prevalence of specific IgG antibodies between
males and females [5]. The high seroprevalence in
women can be attributed to women’s engagement in
non-occupational “peridomestic” work, such as cleaning
of sheds and summer cottages. Notably, females also
perform much of the farm- and forestry work in rural
and farming families which poses a risk for exposure to
rodent excreta through handling of e.g., wood, hay, and
grain [26, 27]. Also, more women work as small scale
entrepreneurs in agricultural tourism, horse-farming
etc., while still holding a main occupation outside the
farm [26]. Participants in our study were only asked to
report their main occupation, thus such agricultural
work was hidden.
Although PUUV has been detected in human saliva,
implicating a possible risk for person-to-person transmis-
sion [9], no increased risks for healthcare workers were
found in the present as well as in earlier studies [5].
PUUV infection is correlated to an increased risk for
cardiovascular complications i.e., stroke and myocardial
infarction [15]. Moreover, some patients suffer from long
lasting fatigue. A possible explanation could be impaired
lung function [14] but also endocrine deficiencies seem
to be common among hospitalized patients with PUUV
infection [16]. Some of these deficiencies have been
noted for years after recovery from HFRS. It is currently
unknown if there are sex-differences in long-term effects
of hantavirus-infection. The physical and psychological
effects of a potential hypopituitarism after HFRS warrant
increased awareness.
A study from Finland, showed higher glomerular filtra-
tion rate (GFR) and higher systolic blood pressure in
patients who had been diagnosed with PUUV infection
3–7 years earlier, compared to a healthy, seronegative
control group [18]. However, in a 10 year follow up, both
GFR and blood pressure had normalized and was equal
in the groups [17]. Another prospective study published
2009 confirmed the findings relatively early after infec-
tion, with higher GFR and systolic blood pressure 6 years
after PUUV infection [28]. On the other hand, a Swedish
study involving 682 seronegative and 110 seropositive
participants in an endemic area in Northern Sweden did
not show any differences in blood pressure between the
groups [19]. In the present study, there was no signifi-
cant elevation of blood pressure or GFR, and no
higher incidence of diabetes, acute myocardial infarc-
tion or cerebrovascular insult were found among the
seropositive group i.e., those that had a previous
PUUV infection.
For detection of PUUV IgG by ELISA we used the
full-length nucleocapsid protein, while a previous study
used a truncated nucleocapsid protein [5]. An ELISA
based on the full-length protein was more sensitive for
detection of PUUV IgM, but the sensitivity for long-
standing PUUV IgG has not been assessed [29]. In
regard to these circumstances there might be a some-
what higher sensitivity in the present study but that
cannot alone explain the increase in PUUV seropreva-
lence in the population of northern Sweden. Limitations
of the present study was the lack of knowledge regarding
the year of PUUV infection as well as few reported cases
of other illnesses in the material, reflecting the age
groups of the study population. Moreover, the studies
confirming an association between past PUUV infection
and elevated blood pressure and/or renal impairment
were mainly conducted on hospitalized patients, indicat-
ing a relatively severe form of PUUV infection [18, 28].
It seems likely that the severity of the infection is
important for potential sequelae, but long term conse-
quences have been described also after a relatively mild
course of PUUV infection [30]. Our study design did not
allow for defining the severity of the illness, and
additional research of possible comorbidity in hantavirus
endemic areas is desirable.
Conclusions
We have investigated the seroprevalence of Puumala
hantavirus that causes haemorrhagic fever with renal
syndrome in northern Sweden using a large, randomized
and population based cohort.
PUUV antibody presence in serum samples from 1,600
participants was analysed and 13 % were found to be
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positive. This is substantially higher than previous studies
in the same area and might be explained by several PUUV
outbreaks in the region, including the large outbreak in
2007. In the older population (65–75 years) as many as
one in five individuals have had a PUUV infection and
was more common in men than in women.
Smoking, living in rural areas, and owning farmland or
forest was identified as risk factors for contracting a PUUV
infection. Increased awareness in risk areas, appropriate
protection from rodent secreta, and possibly a future vac-
cine would be of value for the identified high-risk groups.
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Additional file 1: Table S1. Self-assessed health and reported disease
in relation to Puumala virus (PUUV) seropositivity. (DOCX 73 kb)
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